Mirati Therapeutics(MRTX) - 2021 Q1 - Quarterly Report
Mirati TherapeuticsMirati Therapeutics(US:MRTX)2021-05-06 20:37

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or 3545 Cray Court, San Diego, California 92121 (Address of Principal Executive Of ices) (Zip Code) (858) 332-3410 (Registrant's Telephone Number, Including Area Code) ______________________________________________________ Securities registered pursuant to Section 12(b) of the Act: | Title of ...